CPHI — CHINA PHARMA HOLDINGS, INC.
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1106644 ·
Last close
$0.50
Market Cap
$21.51M
52W High
$19.19
52W Low
$0.38
ADV30
3,167,784
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 948,340 | 83,566 | -1,431,845 | -1,458,123 | 44,709,903 | 304,874 | 8,528,623 |
| Mar 2026 | 983,536 | 285,487 | -1,117,264 | -1,143,148 | 45,143,790 | 168,474 | 8,119,600 |
| Dec 2025 | 1,225,997 | 150,775 | -1,200,762 | -1,222,135 | 30,999,464 | 345,112 | 8,259,712 |
| Sep 2025 | 756,217 | -59,654 | -627,730 | -651,482 | 15,804,793 | 267,625 | 7,490,796 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-140,490
Investing CF
$-78,992
Financing CF
$-154,013
CapEx
$-169,878
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.41
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-49,815,506
Inventory
$1,362,423
Receivables
$250,073
ST Investments
—
EBIT TTM
$-4,375,848
Pretax Income TTM
$-4,474,888
Interest Exp TTM
$99,040
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,914,090
EBITDA
$-1,440,699
Free Cash Flow
$1,106,281
Enterprise Value
$36,460,924
Total Cash
$304,874
Total Debt
$4,056,171
Shares Out
43,022,002
Trailing EPS
$-0.42
Book Value
$0.89
ROE
-21.0%
ROA
-9.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 4,144,268 | -3,088,540 | -3,187,556 | 30,999,464 | 8,259,712 | 22,739,752 | 148,261 |
| Dec 2024 | 4,528,929 | -4,583,164 | -4,736,365 | 14,887,524 | 7,139,620 | 7,747,904 | -406,063 |
| Dec 2023 | 7,011,299 | -2,767,577 | -3,078,818 | 16,469,200 | 9,014,579 | 7,454,621 | -699,686 |
| Dec 2022 | 8,104,092 | -3,642,828 | -3,972,841 | 17,784,143 | 13,494,145 | 4,289,998 | -409,545 |
TTM Snapshot
Revenues TTM
$3,914,090
NetIncome TTM
$-4,474,888
OpCashFlow TTM
—
Assets (Latest)
$44,709,903
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IXHL | Incannex Healthcare Inc. | $21.83M | $1.74 | — |
| TXMD | TherapeuticsMD, Inc. | $22.11M | $1.91 | — |
| CUE | Cue Biopharma, Inc. | $20.56M | $2.83 | — |
| CRVO | CervoMed Inc. | $22.68M | $1.50 | — |
| BYSI | BeyondSpring Inc. | $23.02M | $0.56 | — |
News headlines (Yahoo Finance, 1h cache)
China Pharma Holdings, Inc. Announces Closing of $5.0 Million Registered Direct Offering
2026-07-23 22:49 · Yahoo
China Pharma Announces Pricing of $5 Million Registered Direct Offering
2026-07-22 13:25 · Yahoo
China Pharma Holdings, Inc. Comments on Unusual Market Activity
2026-07-21 20:00 · Yahoo
China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity
2026-05-14 12:56 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.